Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $64.67 Consensus PT from Analysts
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have received an average rating of “Buy” from the ten analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating, six have issued a buy rating and three have assigned a strong buy rating to the […]
Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have received an average rating of “Buy” from the ten analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating, six have issued a buy rating and three have assigned a strong buy rating to the […]
